BIIB logo

Biogen Inc. (BIIB) EBITDA

Annual EBITDA:

$2.83B+$791.00M(+38.80%)
December 31, 2024

Summary

  • As of today, BIIB annual EBITDA is $2.83 billion, with the most recent change of +$791.00 million (+38.80%) on December 31, 2024.
  • During the last 3 years, BIIB annual EBITDA has fallen by -$50.60 million (-1.76%).
  • BIIB annual EBITDA is now -63.74% below its all-time high of $7.80 billion, reached on December 31, 2019.

Performance

BIIB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

Quarterly EBITDA:

$816.00M-$224.60M(-21.58%)
September 30, 2025

Summary

  • As of today, BIIB quarterly EBITDA is $816.00 million, with the most recent change of -$224.60 million (-21.58%) on September 30, 2025.
  • Over the past year, BIIB quarterly EBITDA has increased by +$137.40 million (+20.25%).
  • BIIB quarterly EBITDA is now -55.98% below its all-time high of $1.85 billion, reached on June 30, 2020.

Performance

BIIB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

TTM EBITDA:

$3.24B+$137.40M(+4.42%)
September 30, 2025

Summary

  • As of today, BIIB TTM EBITDA is $3.24 billion, with the most recent change of +$137.40 million (+4.42%) on September 30, 2025.
  • Over the past year, BIIB TTM EBITDA has increased by +$494.60 million (+18.00%).
  • BIIB TTM EBITDA is now -52.03% below its all-time high of $6.76 billion, reached on June 30, 2020.

Performance

BIIB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BIIB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+38.8%+20.3%+18.0%
3Y3 Years-1.8%+5.3%+21.4%
5Y5 Years-63.7%-19.0%-46.6%

BIIB EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-35.1%+38.8%-21.6%+158.9%at high+52.5%
5Y5-Year-63.7%+38.8%-21.6%+140.0%-46.6%+326.8%
All-TimeAll-Time-63.7%+451.9%-56.0%+140.0%-52.0%+8288.6%

BIIB EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$816.00M(-21.6%)
$3.24B(+4.4%)
Jun 2025
-
$1.04B(+34.9%)
$3.11B(+8.0%)
Mar 2025
-
$771.50M(+25.5%)
$2.88B(+2.8%)
Dec 2024
$2.83B(+38.8%)
$614.60M(-9.4%)
$2.80B(+1.8%)
Sep 2024
-
$678.60M(-16.3%)
$2.75B(+15.2%)
Jun 2024
-
$811.20M(+17.1%)
$2.38B(+5.3%)
Mar 2024
-
$693.00M(+22.6%)
$2.26B(+6.5%)
Dec 2023
$2.04B(-53.2%)
$565.30M(+79.3%)
$2.13B(-8.1%)
Sep 2023
-
$315.20M(-54.4%)
$2.31B(-16.6%)
Jun 2023
-
$690.60M(+24.4%)
$2.77B(-6.6%)
Mar 2023
-
$555.00M(-26.3%)
$2.97B(+1.5%)
Dec 2022
$4.36B(+51.3%)
$752.80M(-2.9%)
$2.93B(+9.5%)
Sep 2022
-
$775.30M(-12.6%)
$2.67B(-2.6%)
Jun 2022
-
$887.50M(+74.0%)
$2.74B(-4.0%)
Mar 2022
-
$510.00M(+2.2%)
$2.85B(-13.5%)
Dec 2021
$2.88B(-49.8%)
$499.10M(-41.0%)
$3.30B(+334.4%)
Sep 2021
-
$845.50M(-15.5%)
$759.70M(-17.6%)
Jun 2021
-
$1.00B(+4.7%)
$921.50M(-48.1%)
Mar 2021
-
$955.30M(+146.8%)
$1.77B(-30.0%)
Dec 2020
$5.73B(-26.5%)
-$2.04B(-302.7%)
$2.54B(-58.3%)
Sep 2020
-
$1.01B(-45.7%)
$6.08B(-10.1%)
Jun 2020
-
$1.85B(+7.9%)
$6.76B(+2.3%)
Mar 2020
-
$1.72B(+14.6%)
$6.61B(+5.0%)
Dec 2019
$7.80B(+14.0%)
$1.50B(-11.4%)
$6.29B(-0.7%)
Sep 2019
-
$1.69B(-0.8%)
$6.34B(+0.1%)
Jun 2019
-
$1.70B(+21.7%)
$6.34B(+9.7%)
Mar 2019
-
$1.40B(-9.3%)
$5.78B(-0.6%)
Dec 2018
$6.85B(+6.0%)
$1.54B(-8.5%)
$5.81B(+2.1%)
Sep 2018
-
$1.69B(+47.2%)
$5.69B(+1.7%)
Jun 2018
-
$1.15B(-20.2%)
$5.59B(-1.0%)
Mar 2018
-
$1.44B(+1.0%)
$5.65B(+3.7%)
Dec 2017
$6.46B(+10.0%)
$1.42B(-10.5%)
$5.45B(-2.2%)
Sep 2017
-
$1.59B(+32.4%)
$5.57B(+4.9%)
Jun 2017
-
$1.20B(-3.0%)
$5.31B(-2.0%)
Mar 2017
-
$1.24B(-19.9%)
$5.42B(+0.3%)
Dec 2016
$5.88B(+7.6%)
$1.54B(+15.9%)
$5.41B(+40.0%)
Sep 2016
-
$1.33B(+1.6%)
$3.86B(+4.7%)
Jun 2016
-
$1.31B(+7.6%)
$3.69B(+8.8%)
Mar 2016
-
$1.22B(+5.1%)
$3.39B(-23.1%)
Dec 2015
$5.46B(+17.1%)
-
-
Sep 2015
-
$1.16B(+14.6%)
$4.41B(+3.7%)
Jun 2015
-
$1.01B(+8.9%)
$4.25B(+3.4%)
Mar 2015
-
$929.06M(-28.9%)
$4.11B(+9.0%)
Dec 2014
$4.66B(+53.2%)
$1.31B(+30.5%)
$3.77B(+24.4%)
Sep 2014
-
$1.00B(+14.6%)
$3.03B(+17.5%)
Jun 2014
-
$873.58M(+48.3%)
$2.58B(+16.4%)
Mar 2014
-
$589.05M(+4.1%)
$2.22B(+8.9%)
Dec 2013
$3.04B(+34.9%)
$565.87M(+2.8%)
$2.04B(+17.0%)
Sep 2013
-
$550.56M(+7.8%)
$1.74B(+13.9%)
Jun 2013
-
$510.67M(+25.1%)
$1.53B(+12.8%)
Mar 2013
-
$408.16M(+51.1%)
$1.35B(+19.0%)
Dec 2012
$2.26B(+7.3%)
$270.04M(-20.1%)
$1.14B(-2.6%)
Sep 2012
-
$337.89M(+0.0%)
$1.17B(-1.6%)
Jun 2012
-
$337.74M(+76.2%)
$1.19B(+7.0%)
Mar 2012
-
$191.66M(-36.3%)
$1.11B(-7.3%)
Dec 2011
$2.10B(+29.7%)
$300.73M(-15.8%)
$1.20B(-13.7%)
Sep 2011
-
$356.96M(+37.1%)
$1.39B(+11.8%)
Jun 2011
-
$260.41M(-6.6%)
$1.24B(+2.0%)
Mar 2011
-
$278.81M(-43.2%)
$1.22B(+4.6%)
Dec 2010
$1.62B(-9.7%)
$490.55M(+133.0%)
$1.16B(+19.0%)
Sep 2010
-
$210.56M(-10.6%)
$977.15M(-6.9%)
Jun 2010
-
$235.53M(+4.4%)
$1.05B(+7.7%)
Mar 2010
-
$225.68M(-26.1%)
$974.46M(-2.5%)
Dec 2009
$1.80B(+7.6%)
$305.38M(+7.9%)
$999.49M(+9.3%)
Sep 2009
-
$283.06M(+76.5%)
$914.75M(+13.1%)
Jun 2009
-
$160.34M(-36.0%)
$808.50M(-8.4%)
Mar 2009
-
$250.70M(+13.6%)
$882.90M(+2.7%)
Dec 2008
$1.67B(+25.4%)
$220.63M(+24.8%)
$859.73M(-2.0%)
Sep 2008
-
$176.82M(-24.7%)
$876.93M(+9.1%)
Jun 2008
-
$234.74M(+3.2%)
$803.54M(+12.4%)
Mar 2008
-
$227.54M(-4.3%)
$715.20M(+12.7%)
Dec 2007
$1.33B(+53.2%)
$237.84M(+130.0%)
$634.46M(+18.8%)
Sep 2007
-
$103.42M(-29.4%)
$534.09M(-8.3%)
Jun 2007
-
$146.40M(-0.3%)
$582.51M(+6.5%)
Mar 2007
-
$146.80M(+6.8%)
$547.05M(-4.7%)
Dec 2006
$868.93M(+30.1%)
$137.48M(-9.5%)
$573.79M(+10.6%)
Sep 2006
-
$151.84M(+36.9%)
$518.61M(+33.1%)
Jun 2006
-
$110.93M(-36.1%)
$389.72M(-22.0%)
Mar 2006
-
$173.53M(+110.9%)
$499.48M(-0.8%)
Dec 2005
$668.05M
$82.30M(+258.6%)
$503.53M(-14.4%)
Sep 2005
-
$22.95M(-89.6%)
$588.30M(-23.4%)
Jun 2005
-
$220.69M(+24.3%)
$768.37M(+17.6%)
DateAnnualQuarterlyTTM
Mar 2005
-
$177.59M(+6.3%)
$653.19M(+30.5%)
Dec 2004
$522.43M(+165.0%)
$167.08M(-17.7%)
$500.65M(+43.0%)
Sep 2004
-
$203.02M(+92.4%)
$350.07M(+57.5%)
Jun 2004
-
$105.51M(+321.3%)
$222.31M(+33.9%)
Mar 2004
-
$25.04M(+51.8%)
$166.04M(-19.9%)
Dec 2003
-$804.13M(-412.0%)
$16.49M(-78.1%)
$207.24M(-20.8%)
Sep 2003
-
$75.26M(+52.8%)
$261.50M(+7.5%)
Jun 2003
-
$49.25M(-25.7%)
$243.29M(+0.1%)
Mar 2003
-
$66.24M(-6.4%)
$242.98M(+12.2%)
Dec 2002
$257.75M(-40.1%)
$70.76M(+24.0%)
$216.65M(+48.5%)
Sep 2002
-
$57.05M(+16.6%)
$145.89M(+64.2%)
Jun 2002
-
$48.93M(+22.6%)
$88.84M(+122.6%)
Mar 2002
-
$39.91M(+61.5%)
$39.91M(-91.4%)
Dec 2001
$430.47M(-18.8%)
-
-
Mar 2001
-
$24.72M(-90.9%)
$462.90M(-12.7%)
Dec 2000
$530.45M(+52.7%)
$272.95M(+289.7%)
$530.45M(+30.4%)
Sep 2000
-
$70.05M(-26.4%)
$406.85M(-5.0%)
Jun 2000
-
$95.19M(+3.2%)
$428.30M(+2.9%)
Mar 2000
-
$92.27M(-38.2%)
$416.05M(+6.1%)
Dec 1999
$347.35M(+61.4%)
$149.35M(+63.2%)
$392.30M(+11.9%)
Sep 1999
-
$91.50M(+10.3%)
$350.48M(+11.5%)
Jun 1999
-
$82.93M(+21.0%)
$314.28M(+12.9%)
Mar 1999
-
$68.52M(-36.3%)
$278.35M(+10.4%)
Dec 1998
$215.23M(+27.9%)
$107.53M(+94.4%)
$252.03M(+2.5%)
Sep 1998
-
$55.30M(+17.7%)
$245.96M(+10.0%)
Jun 1998
-
$47.00M(+11.4%)
$223.66M(+6.7%)
Mar 1998
-
$42.20M(-58.4%)
$209.56M(+7.1%)
Dec 1997
$168.26M(+200.0%)
$101.46M(+207.5%)
$195.66M(+34.6%)
Sep 1997
-
$33.00M(+0.3%)
$145.39M(-4.9%)
Jun 1997
-
$32.90M(+16.3%)
$152.89M(+37.5%)
Mar 1997
-
$28.30M(-44.7%)
$111.19M(+41.7%)
Dec 1996
$56.09M(+205.5%)
$51.19M(+26.4%)
$78.49M(+30.9%)
Sep 1996
-
$40.50M(+560.2%)
$59.96M(+206.5%)
Jun 1996
-
-$8.80M(-100.0%)
$19.56M(-29.0%)
Mar 1996
-
-$4.40M(-113.5%)
$27.56M(-17.4%)
Dec 1995
$18.36M(+198.6%)
$32.66M(>+9900.0%)
$33.36M(+35.3%)
Sep 1995
-
$100.00K(+112.5%)
$24.65M(+5389.8%)
Jun 1995
-
-$800.00K(-157.1%)
$449.00K(+980.4%)
Mar 1995
-
$1.40M(-94.2%)
-$51.00K(-100.5%)
Dec 1994
$6.15M(-78.3%)
$23.95M(+199.4%)
$9.75M(+151.6%)
Sep 1994
-
-$24.10M(-1753.8%)
-$18.90M(-227.7%)
Jun 1994
-
-$1.30M(-111.6%)
$14.80M(-45.0%)
Mar 1994
-
$11.20M(+338.3%)
$26.90M(0.0%)
Dec 1993
$28.40M(-20.4%)
-$4.70M(-149.0%)
$26.90M(-53.9%)
Sep 1993
-
$9.60M(-11.1%)
$58.40M(-1.0%)
Jun 1993
-
$10.80M(-3.6%)
$59.00M(+25.8%)
Mar 1993
-
$11.20M(-58.2%)
$46.90M(+33.2%)
Dec 1992
$35.70M(+839.5%)
$26.80M(+162.7%)
$35.20M(+319.0%)
Sep 1992
-
$10.20M(+884.6%)
$8.40M(+660.0%)
Jun 1992
-
-$1.30M(-160.0%)
-$1.50M(-225.0%)
Mar 1992
-
-$500.00K(>-9900.0%)
$1.20M(-69.2%)
Dec 1991
$3.80M(-17.4%)
$0.00(-100.0%)
$3.90M(-39.1%)
Sep 1991
-
$300.00K(-78.6%)
$6.40M(-5.9%)
Jun 1991
-
$1.40M(-36.4%)
$6.80M(+23.6%)
Mar 1991
-
$2.20M(-12.0%)
$5.50M(+25.0%)
Dec 1990
$4.60M(+180.7%)
$2.50M(+257.1%)
$4.40M(+1566.7%)
Sep 1990
-
$700.00K(+600.0%)
-$300.00K(+90.3%)
Jun 1990
-
$100.00K(-90.9%)
-$3.10M(-183.8%)
Mar 1990
-
$1.10M(+150.0%)
$3.70M(-65.4%)
Dec 1989
-$5.70M(+35.2%)
-$2.20M(-4.8%)
$10.70M(+176.4%)
Sep 1989
-
-$2.10M(-130.4%)
-$14.00M(-68.7%)
Jun 1989
-
$6.90M(-14.8%)
-$8.30M(+11.7%)
Mar 1989
-
$8.10M(+130.1%)
-$9.40M(+21.0%)
Dec 1988
-$8.80M(+56.9%)
-$26.90M(-847.2%)
-$11.90M(+25.6%)
Sep 1988
-
$3.60M(-37.9%)
-$16.00M(+10.1%)
Jun 1988
-
$5.80M(+3.6%)
-$17.80M(+18.7%)
Mar 1988
-
$5.60M(+118.1%)
-$21.90M(+9.9%)
Dec 1987
-$20.40M(+18.4%)
-$31.00M(-1822.2%)
-$24.30M(+13.2%)
Sep 1987
-
$1.80M(+5.9%)
-$28.00M(+3.8%)
Jun 1987
-
$1.70M(-46.9%)
-$29.10M(-1.0%)
Mar 1987
-
$3.20M(+109.2%)
-$28.80M(+1.4%)
Dec 1986
-$25.00M(+12.0%)
-$34.70M(-5057.1%)
-$29.20M(+26.3%)
Sep 1986
-
$700.00K(-65.0%)
-$39.60M(-9.1%)
Jun 1986
-
$2.00M(-28.6%)
-$36.30M(-9.3%)
Mar 1986
-
$2.80M(+106.2%)
-$33.20M(-0.6%)
Dec 1985
-$28.40M(-77.5%)
-$45.10M(-1227.5%)
-$33.00M(-38.1%)
Sep 1985
-
$4.00M(-21.6%)
-$23.90M(-8.6%)
Jun 1985
-
$5.10M(+70.0%)
-$22.00M(-2.8%)
Mar 1985
-
$3.00M(+108.3%)
-$21.40M(-5.9%)
Dec 1984
-$16.00M
-$36.00M(-710.2%)
-$20.20M(-227.8%)
Sep 1984
-
$5.90M(+3.5%)
$15.80M(+59.6%)
Jun 1984
-
$5.70M(+35.7%)
$9.90M(+135.7%)
Mar 1984
-
$4.20M
$4.20M

FAQ

  • What is Biogen Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Biogen Inc.?
  • What is Biogen Inc. annual EBITDA year-on-year change?
  • What is Biogen Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Biogen Inc.?
  • What is Biogen Inc. quarterly EBITDA year-on-year change?
  • What is Biogen Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Biogen Inc.?
  • What is Biogen Inc. TTM EBITDA year-on-year change?

What is Biogen Inc. annual EBITDA?

The current annual EBITDA of BIIB is $2.83B

What is the all-time high annual EBITDA for Biogen Inc.?

Biogen Inc. all-time high annual EBITDA is $7.80B

What is Biogen Inc. annual EBITDA year-on-year change?

Over the past year, BIIB annual EBITDA has changed by +$791.00M (+38.80%)

What is Biogen Inc. quarterly EBITDA?

The current quarterly EBITDA of BIIB is $816.00M

What is the all-time high quarterly EBITDA for Biogen Inc.?

Biogen Inc. all-time high quarterly EBITDA is $1.85B

What is Biogen Inc. quarterly EBITDA year-on-year change?

Over the past year, BIIB quarterly EBITDA has changed by +$137.40M (+20.25%)

What is Biogen Inc. TTM EBITDA?

The current TTM EBITDA of BIIB is $3.24B

What is the all-time high TTM EBITDA for Biogen Inc.?

Biogen Inc. all-time high TTM EBITDA is $6.76B

What is Biogen Inc. TTM EBITDA year-on-year change?

Over the past year, BIIB TTM EBITDA has changed by +$494.60M (+18.00%)
On this page